Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  varenicline
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-21 of 21 for your search:
Start Over
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Phase: Phase IV
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: R21MH087928, NCT01010204
Pharmacogenetics, Emotional Reactivity and Smoking
Phase: Phase III, Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: 2003-1024, 1R01DA017073, NCI-2012-02108, NCT00507728
Varenicline and Bupropion for Smoking Cessation
Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-003598, 09-002459, 1RO1CA138417, NCT00935818
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
Phase: Phase III
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: Pro00013846, NCT00894166
Combining Varenicline and Bupropion for Smoking Cessation
Phase: Phase III
Type: Educational/Counseling/Training, Prevention
Status: Closed
Age: 25 to 65
Sponsor: NCI, Other
Protocol IDs: 2008-0850, R01DA024709-01A1, NCI-2011-01101, NCT00943618
Smoking Cessation for American Indians
Phase: Phase III
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 11862, R01 CA141618, NCT01106456
Smoking Cessation Intervention for Thoracic Patients
Phase: Phase II, Phase I
Type: Behavioral study
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2007p-000838, 1 R03 CA130722-01, NCT00580398
An Alternative Dosing Schedule of Varenicline for Smoking Cessation
Phase: Phase II
Type: Behavioral study, Prevention
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: I 136208, Pfizer IIR-GA30523, NCT00835900
Contingency Management and Pharmacotherapy for Smoking Cessation
Phase: Phase II
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-035-3, DF 07-028, NCT00683280
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking?
Phase: Phase II
Type: Behavioral study, Prevention
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: HIC0702002391, R01AA015596-01, NCT00580645
Varenicline for Smoking Cessation in Heavy Drinking Smokers
Phase: Phase II
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: NIAAA-O'Malley-P50AA15632-2009, P50AA015632, NCT00860028
Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
Phase: Phase II
Type: Behavioral study
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: MEC 08-5-066, ZonMw 40-00812-98-07-004, ZonMw 61200014, Nabi-4508, NCT00995033
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000616663, R01CA129226, BUTLER-0807-004, 0807-004, NCT00790569
Exercise or Relaxation for Smoking Cessation
Phase: No phase specified
Type: Behavioral study
Status: Closed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: 09-097-2, 1RO1 DA024872-01A1, NCT00921388
Smoking Cessation Using Motivational Therapy and Varenicline
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: NHLBI
Protocol IDs: 2007H0173, R01HL090313, NCT00701896
A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control
Phase: No phase specified
Type: Behavioral study, Natural history/Epidemiology, Prevention
Status: Completed
Age: 18 to 55
Sponsor: Other
Protocol IDs: 999909044, 09-DA-N044, NCT00830739
Smoking Cessation Treatment for Head & Neck Cancer Patients
Phase: No phase specified
Type: Behavioral study
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2009-0362, NCI-2011-02004, 1R01CA120153-01A2, NCT01098955
Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Completed
Age: 20 to 60
Sponsor: Other
Protocol IDs: SPCRU1, NCT01176383
Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)
Phase: No phase specified
Type: Behavioral study, Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-136, NCT01532232
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 221312, NCI-2012-02755, NCT01771627
Start Over